RxDoctor Payments Data

Denise Huskey, MD

Family Medicine · Wichita, KSNPI 1376760108

Payments from drug & device makers

$858in general payments, 2019–2025

Across 70 payments — averaging $12.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$154
  • Pfizer$127
  • Novo Nordisk$119
  • Lilly USA, LLC$113
  • Takeda Pharmaceuticals U.S.A., Inc.$42
  • Boehringer Ingelheim$36
  • plus $267 from 13 others

What the payments were for

  • Food & beverage$81795%
  • Education$425%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$858 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$179,478
Medicare patients
376
Services billed
3,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$102,022
JardianceEmpagliflozin145$97,153
TrulicityDulaglutide69$80,891
EliquisApixaban89$66,037
MounjaroTirzepatide56$62,718
MyrbetriqMirabegron53$30,059
Tresiba Flextouch U-200Insulin Degludec30$27,408
FarxigaDapagliflozin Propanediol29$25,268
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$22,610
XareltoRivaroxaban15$20,892
Soliqua 100-33Insulin Glargine/Lixisenatide24$20,526
ProliaDenosumab12$20,437
RybelsusSemaglutide13$12,815
TrintellixVortioxetine Hydrobromide19$11,008
Tresiba Flextouch U-100Insulin Degludec31$10,001

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$113$143,609125 claims
Novo NordiskOzempic, Rybelsus$119$114,837117 claims
Boehringer IngelheimJardiance$36$97,153145 claims
PfizerEliquis$127$66,03789 claims
Astellas Pharma US IncMyrbetriq, Veozah$27$38,17364 claims
Johnson & JohnsonXarelto$12$20,89215 claims
AmgenProlia$154$20,43712 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$42$11,00819 claims
AbbVieSynthroid$26$4,82872 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →